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Abstract
Endometriosis is a major cause of infertility and pelvic pain, affecting more than 10% of 
reproductive-aged women. Progesterone resistance has been observed in the endometrium of 
women with this disease, as evidenced by alterations in progesterone-responsive gene and protein 
expression. cAMP-Response Element-Binding 3-like protein 1 (Creb3l1) has previously been 
identified as a progesterone receptor (PR) target gene in mouse uterus via high density DNA 
microarray analysis. However, CREB3L1 function has not been studied in the context of 
endometriosis and uterine biology. In this study, we validated progesterone (P4) regulation of 
Creb3l1 in the uteri of wild-type and progesterone receptor knockout (PRKO) mice. Furthermore, 
we observed that CREB3L1 expression was significantly higher in secretory phase human 
endometrium compared to proliferative phase and that CREB3L1 expression was significantly 
decreased in the endometrium of women with endometriosis. Lastly, by transfecting CREB3L1 
siRNA into cultured human endometrial stromal cells (hESCs) prior to hormonal induction of in 
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vitro decidualization, we showed that CREB3L1 is required for the decidualization process. 
Interestingly, phosphorylation of ERK1/2, critical factor for decidualization, was also significantly 
reduced in CREB3L1-silenced hESCs. It is known that hESCs from patients with endometriosis 
show impaired decidualization and that dysregulation of the P4-PR signaling axis is linked to a 
variety of endometrial diseases including infertility and endometriosis. Therefore, these results 
suggest that CREB3L1 is required for decidualization in mice and humans and may be linked to 
the pathogenesis of endometriosis in a P4-dependent manner.
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Introduction
The uterine endometrium is comprised of epithelial and stromal cell compartments that 
undergo dynamic molecular and morphological changes to allow for embryo implantation 
and development. These components are tightly regulated by the ovarian steroid hormones, 
estrogen (E2) and progesterone (P4) [1]. E2 is known to stimulate uterine epithelial cell 
proliferation whereas P4 inhibits this E2 effect, presumably through coordination of stromal-
epithelial cell cross-talk. The progesterone receptor (PR) is required for successful 
implantation in both humans and rodents. PR signaling has been shown to regulate 
implantation-associated events including the development of uterine receptivity and 
endometrial stromal cell decidualization [2]. Studies utilizing a transgenic mouse model 
with a null mutation in the PR gene (PRKO) demonstrate the essential role for PR in P4-
mediated uterine responses [3, 4], and have led to the identification of several P4-PR- 
signaling pathways within the uterus [5].
During early pregnancy, endometrial stromal cells are transformed into decidual cells in a 
P4-dependent manner. Decidualization is unique to species with hemichorial placentation, 
such as human, non-human primates and rodents and serves to protect the maternal uterus 
during trophoblast invasion and provide nourishment to the early embryo [6]. Endometrial 
stromal cells undergoing decidualization become plumper, acquire a secretory epithelioid-
like morphology and secrete a variety of factors, including prolactin (PRL) and insulin-like 
growth factor binding protein 1 (IGFBP1) [7]. Moreover, this transformation results in 
extensive changes in cellular gene expression, including alterations in steroid hormone 
receptor, extracellular matrix (ECM) and cytoskeletal gene profiles [8, 9]. Multiple 
transgenic mouse models have shown that the decidualization process is essential for the 
maintenance of pregnancy [3, 10, 11].
Imbalances in steroid signaling have been linked with multiple pathologies, including 
infertility, endometriosis, endometrial carcinoma, polycystic ovarian syndrome, and 
leiomyomas [12–15]. Each of these diseases displays a characteristic dysregulation of ER 
and PR expression profiles as well as their downstream target genes. All of these disorders 
are associated with increased E2 sensitivity, as characterized by decreased E2 metabolism 
and increased ER expression [12–15]. However, mounting evidence now links P4 
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dysregulation to these diseases as well. Loss of functional PR signaling has been shown to 
contribute to P4 resistance, at either the level of PR itself or its downstream target genes, 
which ultimately can disrupt critical epithelial-stromal cross talk within the uterus [16–18].
Endometriosis, a benign gynecological disease defined as the presence of endometrial cells 
outside the uterus, seriously impacts the quality of life and reproductive ability of 6–10% of 
reproductive-aged women and is strongly associated with chronic pelvic pain and infertility 
[19]. Disrupted steroidal control of uterine cell proliferation as well as abnormal 
decidualization have been shown in women with this disease [20]. Furthermore, P4 exposure 
is a negative risk factor for endometriosis [21], as pregnancy or progestin-based therapies are 
associated with disease regression in some women [22, 23]. However, a subset of women 
with this disease is non-responsive to frontline progestin treatments. Moreover, P4-induced 
molecular changes in the eutopic (intrauterine) endometrial tissue of this cohort are either 
blunted or undetectable. These in vivo observations suggest a resistance to P4 action in 
endometriosis [24]. Therefore, understanding the role of the progesterone receptor and its 
target genes will be key to the development of new therapeutic strategies [25, 26].
cAMP-Response Element-Binding 3-like protein 1 (CREB3L1), also known as Old 
Astrocyte Specifically Induced Substrate (OASIS), is an endoplasmic reticulum unfolded 
protein response (UPR) transducer [27]. In mammalian cells, the UPR family is comprised 
of three members: Inositol Requiring Element 1 (IRE1), PKR-like ER kinase (PERK), and 
Activating Transcription Factor (ATF-6) [27]. CREB3L1 is most structurally similar to 
ATF-6 [28, 29], a basic leucine zipper (bZIP) transcription factor, and located at the ER 
membrane under normal conditions. Upon UPR signaling, the N-terminal cytoplasmic 
domain of CREB3L1 is cleaved, translocates into the nucleus and alters target gene 
expression [29–31]. CREB3L1 is expressed in a variety of tissues including pancreas, 
prostate, and intestine [32, 33]. Furthermore, previous studies suggest that CREB3L1 has a 
role in the differentiation and development of astrocytes, osteoblasts, odontoblasts, 
pancreatic beta-cells and large intestine goblet cells [28–30, 33–35].
Previous studies have identified Creb3l1 as a PR target gene using high density DNA 
microarray analysis [36]. However, the function of CREB3L1 in the female reproductive 
tract is unclear. In this study, we examined the endometrial expression profile of CREB3L1 
during the human menstrual cycle as well as its expression in women with and without 
endometriosis. To investigate the function of CREB3L1, we used the well-characterized in 
vitro primary human endometrial stromal cell decidualization model. Our results show that 
attenuation of CREB3L1 expression via small interfering RNA (siRNA) significantly 
reduced decidualization. We also observed reduced expression of CREB3L1 in the eutopic 
endometrium of women with endometriosis, as compared to healthy controls, suggesting 
that loss of CREB3L1 expression is an important factor in the pathogenesis of 
endometriosis.
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Materials and Methods
Animal and tissue collection
Animals were maintained in a designated animal care facility according to the Michigan 
State University’s Institutional Guidelines for the care and use of laboratory animals. All 
animal procedures were approved by the Institutional Animal Care and Use Committee of 
Michigan State University. To examine the P4 regulation of Creb3l1 expression, wild type 
C57BL/6 mice and PRKO mice at six weeks age were ovariectomized. After two weeks, the 
mice were given a subcutaneous injection of either vehicle (sesame oil) or P4 (1 mg/mice) 
(n=3 per genotype). Six hours later, uterine tissues were dissected, flash-frozen and stored at 
−80°C for RNA /protein extraction and/or fixed in 4% (v/v) paraformaldehyde for 
immunohistochemistry.
Human endometrium samples
The human endometrial samples used to examine CREB3L1 expression patterns were 
obtained from Michigan State University’s Center for Women’s Health Research Female 
Reproductive Tract Biorepository, the Greenville Hospital System, and the University of 
North Carolina in accordance with the guidelines set by the Institutional Review Boards of 
Michigan State University (Grand Rapids, MI), Greenville Health System (Greenville, SC) 
and University of North Carolina (Chapel Hill, NC), respectively. Written informed consent 
was obtained from all participants. For experiments examining CREB3L1 expression 
throughout the menstrual cycle, endometrial samples were analyzed from 25 (n=6 
proliferative and n=19 secretory) cycling premenopausal women undergoing hysterectomy 
for benign conditions who were surgically negative for endometriosis and had not been on 
any hormonal therapies for at least three months prior to surgery. Endometrial menstrual 
staging was confirmed by an experienced pathologist familiar with female reproduction. To 
compare CREB3L1 expression patterns in the eutopic endometrium of women with and 
without endometriosis, 6 control samples were compared to 17 endometriotic samples 
obtained during the early secretory phase. Samples used for immunohistochemistry were 
fixed in 10% buffered formalin prior to embedding in paraffin wax.
Immunohistochemistry
Uterine cross sections from paraffin-embedded tissue were cut into 6 μm sections, mounted 
on silane-coated slides, deparaffinized and rehydrated in a graded alcohol series. Sections 
were pre-incubated with 10% normal goat serum in phosphate-buffered saline (PBS; pH 7.5) 
and then incubated with anti-CREB3L1 (Santa Cruz, Santa Cruz, CA) antibody in PBS 
supplemented with 10% normal goat serum overnight at 4°C. The next day, sections were 
washed with PBS and incubated with secondary antibody conjugated to horseradish 
peroxidase (Vector Laboratories, Burlingame, CA) for 1 hour at room temperature. 
Immunoreactivity was detected using diaminobenzidine (DAB-Vector Laboratories, 
Burlingame, CA) then counterstained with hematoxylin and coverslipped with permount. 
Imuunostaining was analyzed using microscopy software from NIS Elements, Inc. (Nikon, 
Melville, NY).
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Human endometrial stromal cell culture and in vitro decidualization
Human endometrial stromal cells (hESCs), obtained from The Michigan State University’s 
Center for Women’s Health Research Female Reproductive Tract Biorepository with MSU 
Biological Institutional Review Board approval, were isolated by digesting endometrial 
tissue samples with DNase I (Sigma-Aldrich, St. Louis, MO) and collagenase (Sigma-
Aldrich, St. Louis, MO), followed by filtration. Isolated hESCs were then maintained in 
phenol red–free RPMI-1640 medium (Gibco, Grand Island, NY) containing 0.1 mM sodium 
pyruvate (Gibco, Grand Island, NY), 10% fetal bovine serum (FBS; Gibco, Grand Island, 
NY) depleted of steroids by pre-treatment with dextran-coated charcoal (Sigma Aldrich, St. 
Louis, MO) (Charcoal-stripped FBS; CS-FBS), and 1% penicillin streptomycin (P/S; Gibco, 
Grand Island, NY). Cells were cultured in monolayer at 37°C in 5% CO2. To induce in vitro 
decidualization, cells were washed with PBS and transferred to OPTI-MEM medium 
(Gibco, Grand Island, NY) containing 2% CS-FBS, 10 nM estradiol (E2; Sigma-Aldrich, St. 
Louis, MO), 1 mM medroxyprogesterone acetate (MPA; Sigma-Aldrich, St. Louis, MO), 50 
μM cAMP (Sigma-Aldrich, St. Louis, MO), and 1% P/S. Differentiation medium was 
changed every 48 hours for a total of 6 days. For CREB3L1 knockdown, small interfering 
RNA (siRNA) was obtained from Dharmacon (Lafayette, CO), RNAi Techologies. Human 
CREB3L1 siRNA was transfected using Lipofectamine 2000 reagent (Invitrogen Crop., 
Carlsbad, CA) prior to in vitro decidualization.
Immunofluorescence
hESCs were grown on glass coverslips to 90% confluency and subjected to decidualization 
treatment as described above. Upon completion of treatment, coverslips were washed with 
PBS, fixed with 4% paraformaldehyde and permeabilized with 0.1% of Triton X-100 
(Sigma-Aldrich, St. Louis, MO). After further washing, hESCs were exposed to anti-
CREB3L1 (Santa Cruz, Santa Cruz, CA), anti-phospoho-ERK1/2 (Cell Signaling, Danvers, 
MA), or ERK1/2 (Cell Signaling, Danvers, MA) antibodies overnight at 4°C and secondary 
antibody for 2 hour at room temperature. Washed coverslips were then mounted onto 
microscope slides with a DAPI-impregnated mounting media (Vector Laboratories, 
Burlingame, CA) to enable nuclear visualization and images captured via fluorescent 
microscopy (Nikon Instruments Inc., Melville, NY) using software from NIS Elements, Inc. 
(Nikon, Melville, NY).
Western blotting
Cellular proteins were extracted using lysis buffer (10 mM Tris-HCl (pH 7.4), 150 mM 
NaCl, 2.5 mM EDTA, and 0.125% Nonidet P-40 (vol/vol)) supplemented with both a 
protease inhibitor cocktail (Roche, Indianapolis, IN) and a phosphatase inhibitor cocktail 
(Sigma Aldrich, St. Louis, MO). Twenty μg of protein lysates were electrophoresed via 
SDS-PAGE and transferred onto polyvinylidene difluoride membrane (Millipore Corp., 
Bedford, MA). Membrane was blocked with Casein (0.5% v/v) prior to exposure to anti-
phospho ERK1/2 (Cell Signaling, Danvers, MA), anti-ERK1/2 (Cell Signaling, Danvers, 
MA), or anti-Actin (Santa Cruz, Santa Cruz, CA) antibodies. Immunoreactivity was 
visualized by incubation with a horseradish peroxidase-linked secondary antibody followed 
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by exposure to Electrochemiluminescence reagents (ECL) according to manufacturer’s 
instructions (GE Healthcare Biosciences, Piscataway, NJ).
RNA isolation and quantitative real-time PCR
Total RNA was isolated using the RNeasy total RNA isolation kit (Qiagen, Valencia, CA) 
according to manufacturer’s instruction. As a template for quantitative real-time PCR, 
cDNAs were synthesized using quantitative PCR random hexamers and MMLV Reverse 
Transcriptase (Invitrogen Crop., Carlsbad, CA). The expression of CREB3L1, IGFBP1, and 
PRL were quantified by real-time PCR using a CFX96 Real-time Detection System (Bio-
Rad Laboratories, Hercules, CA) and iQ™ SYBR Green Supermix (Bio-Rad Laboratories, 
Hercules, CA). RPL7 expression was included in each treatment group for normalization. 
Gene specific primers used are listed in Table 1.
Statistical Analysis
This semiquantitative approach was used to generate a H-Score for each 
immunohistochemistry sample: the percentage of positive tumor cells per slide (0%–100%) 
was multiplied by intensity strength of staining (0, negative or trace; 1, weak; 2, moderate; 3, 
intense). The overall score ranged from 0 to 300. Statistical analysis were performed using 
one-way ANOVA analysis Tukey’s post hoc multiple range test or Student’s t-tests using the 
Instat package from GraphPad (San Diego, CA). p<0.05 was considered statistically 
significant.
Results
Creb3l1 is identified as P4 and PR target gene in the murine uterus
P4-PR signaling is critical to implantation, decidualization, and glandular development [3, 
37]. Creb3l1 was previously identified as a PR target gene via high density DNA microarray 
analysis [36]. To validate whether Creb3l1 is a P4-PR target gene, ovariectomized wild-type 
or PRKO mice were treated with vehicle (sesame oil) or P4 for 6 hours, then the levels of 
Creb3l1 mRNA were examined using real-time PCR. As shown Figure 1A, the expression of 
Creb3l1 mRNA was significantly increased in the uteri of wild-type mice treated with P4 
compared to vehicle. However, this induction was significantly decreased in PRKO mice 
compared to wild-type mice. These results indicate that the expression of Creb3l1 mRNA is 
mediated by PR. To analyze the uterine localization of CREB3L1 proteins following P4 
treatment, we performed immunohistochemistry using tissues from vehicle or P4-treated 
wild-type and PRKO mice. In the control ovariectomized mouse uterus, CREB3L1 proteins 
were weakly detected in the stroma, and luminal and glandular epithelium. P4 treatment 
remarkably increased the localization of CREB3L1 proteins in the mouse uterus. However, 
CREB3L1 proteins were weakly detectable in PRKO mice treated with either vehicle and P4 
(Figure 1B). These results suggest that Creb3l1 is a novel target gene of the P4-PR signaling 
axis in the uterus.
To investigate the expression of CREB3L1 during early pregnancy, the level of CREB3L1 
was examined in the uteri of female mice during early pregnancy (Figure 2). 
Immunohistochemical analysis of uterine sections revealed that the expression of CREB3L1 
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was weakly detected at 0.5 dpc (days post coitum). Interestingly, strong expression of 
CREB3L1 was present in luminal and glandular epithelium as well as stroma after 2.5 dpc. 
The expression of CREB3L1 was extended into the primary decidual zone at 5.5 dpc, and 
was next observed in the secondary decidual zone at 7.5 dpc. These results show that 
CREB3L1 may be involved in decidualization during early pregnancy.
CREB3L1 is decreased in human endometrium from women with endometriosis
We next used immunohistochemical analysis to examine the cell-specific expression of 
CREB3L1 in endometrium from proliferative phase (n=6), early (n=6), mid (n=8), and late 
(n=5) secretory phase in women (Figure 3). CREB3L1 expression was only weakly 
detectable in epithelial cells of the proliferative phase. CREB3L1 protein was significantly 
higher in endometrial stromal and epithelial cells of the secretory phase as compared to the 
proliferative phase (Figure 3B). Interestingly, we observed that decidual cells have strong 
CREB3L1 staining in the late secretory phase (Figure 3Ah). Because the secretory phase is a 
time of elevated circulating P4 levels, this result suggests P4 regulation of CREB3L1 in 
human endometrium.
We hypothesize that the molecular basis for progesterone resistance in endometriosis is 
related to an overall reduction in progesterone receptor levels (PRs), leading to dysregulation 
of downstream PR target genes [12, 17, 24]. Therefore, to confirm the association of 
CREB3L1 with PR, we examined CREB3L1 expression in secretory endometrium from 
women with (n=17) or without (n=19) endometriosis by immunohistochemistry. 
Interestingly, CREB3L1 protein is significantly lower in endometrium from women with 
endometriosis as compared to controls during the secretory phase (Figure 4).
CREB3L1 is activated in human endometrial stromal cells (hESCs) during in vitro 
decidualization
P4 signaling is crucial for the decidualization of the endometrial stromal cells during early 
pregnancy [2]. Previous studies have shown that eutopic human primary endometrial stromal 
cells (hESCs) from patients with endometriosis showed impaired decidualization [38, 39]. 
To examine the role of CREB3L1 in hESC decidualization, we induced decidualization in 
cultured hESCs by treating the cells with estrogen, MPA, and cAMP [54] and examined 
expression of the known decidualization markers, prolactin (PRL) and insulin-like growth 
factor-binding protein 1 (IGFBP1), as well as cellular morphology. CREB3L1 mRNA 
expression levels were unaltered during in vitro decidualization in hESC (data not shown). 
Since CREB3L1 protein is activated by cleavage of its N-terminal domain which 
translocates from the ER membrane to the nucleus [28–31], we also examined CREB3L1 
protein localization during decidualization by immunofluorescent staining. Our result shows 
that CREB3L1 was consistently expressed in cytoplasm of nondecidualized hESCs. 
However, upon induction of in vitro decidualization, CREB3L1 protein translocated to the 
nucleus on day 3 and day 6 (Figure 5) of treatment. This result suggests that CREB3L1 
protein is activated during in vitro decidualization of hESCs.
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CREB3L1 is required for decidualization in hESCs
To further analyze the role of CREB3L1 in hESC decidualization, we performed siRNA-
mediated knockdown of CREB3L1 expression (Figure 6A). To confirm CREB3L1 
attenuation, we performed real-time PCR and observed decreased CREB3L1 expression in 
the CREB3L1 siRNA group as compared to non-targeting pool siRNA (Figure 6A). 
Surprisingly, hESCs morphology changed markedly upon decidualization treatment, 
showing a reduction in size and shape on day 6 (Figure 6B). The expression of 
decidualization marker genes, IGFBP1 and PRL, were also significantly reduced on day 6 of 
decidualization treatment (Figures 6C and D). These results suggest that CREB3L1 is 
required for both marker gene expression and morphology changes accompanying 
decidualization in hESCs.
CREB3L1 regulates phosphorylation of ERK1/2 in decidualization process
ERK1/2 is a member of the MAPK pathway previously shown to be required for 
endometrial stromal cell decidualization [40]. To determine whether phosphorylation of 
ERK1/2 is regulated by CREB3L1 during in vitro decidualization, we performed western 
blot analysis on protein from hESCs decidualized in the presence or absence of CREB3L1 
siRNA prior to in vitro decidualization. We observed decreased phosphorylation of ERK1/2 
(phospho-ERK1/2) on day 3 and day 6 in hESC treated with CREB3L1 siRNA as compared 
to the non-targeting pool siRNA (Figure 7A). Quantification of phospho-ERK1/2 revealed a 
statistically significantly decrease in phospho-ERK1/2 expression on day 6, as well as a 
marked decrease in phospho-ERK1/2 on day 3, but the latter did not reach statistical 
significance (Figure 7B). It is known that phospho-ERK1/2 translocates from the cytoplasm 
to the nucleus, where it binds to and transcriptionally activates downstream target genes [41, 
42]. Thus, we investigated the localization of both total and phospho-ERK1/2 throughout in 
vitro decidualization of hESCs in the presence or absence of CREB3L1 siRNA transduction. 
This immunofluorescence result showed that levels of nuclear phospho-ERK1/2 were 
markedly reduced in decidualized hESCs transfected with CREB3L1 siRNA as compared to 
those transfected with non-targeting pool siRNA (Figure 7C). However, total ERK1/2 levels 
in hESCs were unchanged by CREB3L1 siRNA transfection (Supplemental Figure 1). These 
results suggest that CREB3L1 regulates the activation of phospho-ERK1/2 during the 
decidualization process.
Discussion
In this study, we have characterized Creb3l1 as a P4-PR regulated gene in mouse uterus. P4 
is a known critical regulator of the reproductive events associated with embryo implantation, 
decidualization and the maintenance of pregnancy [43–45]. Previous studies have shown that 
P4 regulation is dependent upon progesterone receptor (PR) [3, 4]. The binding of P4 to PR 
results in PR nuclear translocation and subsequent alteration of P4 target gene transcription. 
Recently, Rubel et al. identified uterine PR-regulated mechanisms and downstream targets 
via chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) [36]. This 
study provided an important dataset for identification of target genes in the uterus regulated 
by the P4-PR axis. These ChIP-Seq results also show that PR directly binds to the proximal 
promoter region of Creb3l1 gene in uteri of ovariectomized mice treated with P4. Our study 
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has shown that CREB3L1 proteins were strongly detected in luminal and glandular 
epithelium as well as stroma of mouse uteri after 2.5 dpc. CREB3L1 proteins were 
significantly increased in both epithelial and stromal compartments of the human 
endometrium at the secretory phase as compared to the proliferative phase. The secretory 
phase of humans and 2.5 dpc of mice are characterized by elevated P4 levels [46]. 
Furthermore, decidual cells also have strong CREB3L1 staining in mice and humans. 
Therefore, our results support that CREB3L1 may play an important role for P4-PR 
signaling in both mice and humans.
Progesterone resistance has been hypothesized as a crucial element in the development of 
endometriosis [12, 24]. The interruption of P4 signaling, occurring from either loss of the 
PR itself or its interacting partners/downstream effectors, leads to a physiological state of P4 
resistance [36]. Aberrant expression of critical P4 target genes such as aromatase, 
leukaemia-inhibitory factor, matrix metalloproteinases and the progesterone receptor has 
previously been shown in the endometrium of women with endometriosis [47–50]. This 
study demonstrates that CREB3L1 expression is also altered in the endometrium from 
women with endometriosis. Similar identification of P4 target genes and signaling pathways 
will be crucial for understanding the uterine dysfunction caused by this disease and 
contribute to the development of new therapeutic interventions.
Our study shows that inhibition of CREB3L1 by siRNA treatment impaired decidualization 
capacity in hESCs, as evidenced by suppression of PRL and IGFBP1 expression, known 
decidualization marker genes. P4 is a steroid hormone closely associated with endometrial 
stromal cell decidualization [2]. hESC from patients with endometriosis [39] and PRKO 
mice demonstrate a decidualization defect, supporting a critical role for P4-PR signaling in 
decidualization in both humans and mice [3]. Previous studies have shown that P4 activates 
Ihh signaling to induce expression of chicken ovalbumin upstream promoter transcription 
factor II (COUP-TFII) during decidualization in hESCs [51, 52]. COUP-TFII, has been 
shown to promote decidualization of hESCs via induction of bone morphogenetic protein 2 
(BMP2) and inhibition of ERα activation [51]. It has also been shown that STAT3 and PR 
crosstalk is required for successful embryo implantation and stromal cell decidualization in 
mice [53, 54]. However, the expression profiles of IHH, COUP-TFII, BMP2, and STAT3 
were not altered in our decidualized hESCs following treatment with CREB3L1 siRNA 
(data not shown), suggesting that CREB3L1 is acting down-stream of these key molecules or 
has an independent function with respect to decidualization.
CREB3L1 functions within the endoplasmic reticulum as an unfolding protein response 
(UPR) sensor [55]. Activation of CREB3L1 is stimulated by the UPR, leading to cleavage of 
its N-terminal domain by the basic leucine zipper (b-ZIP), causing translocation from the 
cytoplasm into the nucleus [29–31]. The cleaved CREB3L1 N-terminal domain then 
transcriptionally activates downstream target genes, such as collagen type I genes, protein-
folding chaperones, and the antiproliferative gene [29–31]. This study reveals that during 
endometrial stromal cell decidualization, CREB3L1 also translocates from the cytoplasm to 
the nucleus, suggesting a role for activated CREB3L1 in decidualization.
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ERK1/2 is activated by phosphorylation, resulting in its translocation from the cytoplasm 
into the nucleus where it phosphorylates target transcription factors [56, 57]. Previous 
studies have shown that ERK1/2 activity is increased in hESCs from women with 
endometriosis [58] and have linked the enhanced proliferation and survival of hESCs derived 
from women with endometriosis with alterations in ERK1/2 signaling [59, 60]. Abnormal 
decidualization of endometrial stromal cells has been correlated with unexplained infertility, 
miscarriage and endometrial pathologies such as endometriosis [20, 61–63]. It has been 
reported that endometriosis patients have a reduced decidualization capacity. Our previous 
studies showed that activation of ERK1/2 signaling coincided with the onset of 
decidualization in mice and humans [40]. Inhibition of ERK1/2 phosphorylation 
significantly decreased this decidualization process. TGF-β superfamily members are key 
regulators of female reproduction including decidualization. TGF-β stimulates activation of 
CREB3L1 [64] and ERK1/2 [65]. Additionally, many studies have demonstrated a potential 
link between ERK1/2 signaling and endometriosis [58, 59, 66]. These results suggest that 
tight regulation of CREB3L1 and ERK1/2 activity is required during the process of 
decidualization.
In this study, total ERK1/2 levels and its localization within hESCs was unchanged by 
CREB3L1 silencing during decidualization. However, phosphorylation of ERK1/2 was 
significantly reduced by CREB3L1 silencing and CREB3L1 expression was required for 
nuclear translocation of phospho-ERK1/2 during hESC decidualization. These results 
suggest that CREB3L1 regulates the accumulation and translocation of phospho-ERK1/2 
during the decidualization process. Previous studies have also shown that in vitro 
decidualization of hESCs from women with endometriosis is characterized by aberrantly 
regulated ERK1/2 phosphorylation [58] and that pretreatment with the ERK1/2 inhibitor, 
U0126, can prevent decidualization [40]. In light of these previous results, we hypothesize 
that phospho-ERK1/2 expression is tightly regulated by CREB3L1 during decidualization.
In summary, Creb3l1 is identified as a target gene of P4-PR in the uterus. Our study 
observed dysregulation of CREB3L1 in endometrium from women with endometriosis as 
compared with healthy controls. Inhibition of CREB3L1 activity by siRNA-mediated 
knockdown suppresses decidualization of hESCs. We also show that phosphorylation of 
ERK1/2, a critical factor for decidualization, was regulated by CREB3L1. These results 
suggest that CREB3L1 is required for successful decidualization in mice and humans and 
have implications for our understanding of endometriosis and other endometrial pathologies.
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Figure 1. 
The expression of CREB3L1 in wild-type (WT) or progesterone receptor knock-out (PRKO) 
mouse. (A) The expression level of Creb3l1 from Progesterone (P4) injected WT or PRKO 
uteri by real-time RT-PCR assay. The samples were prepared from wild-type or PRKO 
uterus that was injected vehicle (Sesami oil) or P4 after 6 hours. The results represent the 
mean ± SEM. **p<0.01, ***p<0.001. (B) The localization pattern of CREB3L1 by 
immunohistochemistry in the vehicle or P4-treated uterus. Uterine sections were collected 
from P4 or vehicle treated WT and PRKO mice for 6 hours. Nuclei were counterstained with 
hematoxylin.
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Figure 2. 
The expression of CREB3L1 during early pregnancy. The localization pattern of CREB3L1 
during natural pregnancy by immunohistochemistry were determined at 0.5 dpc (a and b), 
2.5 dpc (c and d), 3.5 dpc (e and f), 4.5 dpc (g and h), 5.5 dpc (i and j), and 7.5 dpc (k and l).
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Figure 3. 
The expression profile of CREB3L1 in human endometrium during estrus cycle. (A) The 
expression level and localization of CREB3L1 in proliferative (a and b) and early (c and d), 
mid (e and f), and late (g and h) secretory phase of human endometrium. CREB3L1 
expression was high expression in secretary phase endometrial epithelium. Black arrow head 
indicates a decidualized cell. (B) was H-Score by measuring expression intensity of 
endometrial cells. CREB3L1 expression intensity was significantly high level in secretary 
phase endometrium. The results represent the mean ± SEM. *p<0.05, ***p<0.001.
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Figure 4. 
The expression profile of CREB3L1 in secretory endometrium from women with or without 
endometriosis (A) The expression level and localization of CREB3L1 in human 
endometrium with or without endometriosis. CREB3L1 expression was low expression in 
human endometrium with endometriosis. Nuclei were counterstained with hematoxylin. (B) 
H-Score of CREB3L1 expression in human endometrium with or without endometriosis. 
CREB3L1 expression intensity was significantly low level in human endometrium with 
endometriosis. The results represent the mean ± SEM. **p<0.01.
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Figure 5. 
The nuclear translocalization of CREB3L1 during in vitro decidualization of human 
endometrial stromal cells (hESCs). Nuclear localization of CREB3L1 was detected at day 3 
and day 6 in vitro decidualization hESCs with EPC. Neclei were conterstained with DAPI 
staining.
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Figure 6. 
The effect of inhibition of CREB3L1 in human endometrial stromal cells (hESCs) during in 
vitro decidualization. CREB3L1 expression was inhibited by treatment with CREB3L1 
siRNA during in vitro decidualization. (A) The expression of CREB3L1 gene was examined 
during in vitro decidualization. CREB3L1 were significantly decreased in hESCs treated 
with CREB3L1 siRNA during in vitro decidualization. The results represent the mean ± 
SEM. ***p<0.001. (B) Morphological change of hESCs was observed during in vitro 
decidualization on day 3 and day 6. The expression of decidualization marker gene 
IGFBP1(C) and PRL (D) were examined during in vitro decidualization. PRL and IGFBP1 
were significantly decreased in transfected CREB3L1 siRNA hESC during in vitro 
decidualization. The results represent the mean ± SEM. *p<0.05, ***p<0.001.
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Figure 7. 
The regulation of phospho-ERK1/2 by CREB3L1 during hESCs decidualization. (A) The 
expression level of ERK1/2 phosphorylation during CREB3L1 inhibited hESCs 
decidualization. ERK1/2 phosphorylation was decreased at day 3 and day 6 in CREB3L1 
siRNA treatment. (B) Quantification of phospho-ERK1/2 protein level during in vitro 
decidualization with or without CREB3L1 target siRNA treatment. The results represent the 
mean ± SEM. ***p<0.001. (C) Nuclear phospho-ERK1/2 was reduced at day 3 and day 6 in 
vitro decidualization hESCs with CREB3L1 siRNA compared to transfected with non 
targeting pool siRNA. Neclei were conterstained with DAPI staining.
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Table 1
List of gene specific primers used in real-time PCR analysis.
Species Gene name Primer sequence
Mouse
CREB3L1
F 5′-GCCTTCCTGCATTCTCTTCC-3′
R 5′-CCTCTGGCCAGGTCTCTCTC-3′
RPL7
F 5′-TCAATGGAGTAAGCCCAAAG-3′
R 5′-CAAGAGACCGAGCAATCAAG-3′
Human
CREB3L1
F 5′-ACAATGCGCACTTTCCTGAG-3′
R 5′-GAGGGCTCTTCTCATCCAGC-3′
IGFBP1
F 5′-CTATGATGGCTCGAAGGCTC-3′
R 5′-TTCTTGTTGCAGTTTGGCAG -3′
PRL
F 5′-CATCAACAGCTGCCACACTT-3′
R 5′-CGTTTGGTTTGCTCCTCAAT-3′
RPL7
F 5′-AAGAAGCGAATTGCTTTGAC-3′
R 5′-CAAATCCTCCATGCAGATGA-3′
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